Biomarker Development in LGMD2i

Completed

Conditions studied: Muscular Dystrophies, Limb Girdle Muscular Dystrophy

In brief

The overall goal of this natural history study is to define the key LGMD2i phenotypes as measured by standard clinical outcome assessments (COAs), and to validate a muscle biomarker for LGMD2i to support therapeutic development.

Key facts

Study ID
NCT04202627
Run by
ML Bio Solutions, Inc.
People needed
101
Starts
2019-12-01
Expected to finish
2022-10-10
Last updated by the study team
2023-03-29

Who can join

Age: 10 and older, up to 65. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.